Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regions Financial B Pref | RF-B | Jan 15, 2025 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Jan 15, 2025 | 24.77 | +3.51 |
Regions Financial E Pref | RF-E | Jan 15, 2025 | 17.93 | +3.05 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Jan 15, 2025 | 25.58 | +1.71 |
Regis | RGS | Jan 15, 2025 | 23.05 | -0.19 |
Regulus Therapeutics | RGLS | Jan 15, 2025 | 1.27 | +3.67 |
Reinsurance Group of America | RGA | Jan 15, 2025 | 223.08 | +1.58 |
REIT Index ETF Vanguard | VNQ | Jan 15, 2025 | 87.89 | +0.57 |
Reitar Logtech | RITR | Jan 15, 2025 | 3.26 | -2.40 |
Rekor Systems | REKR | Jan 15, 2025 | 1.54 | +7.32 |
Relay Therapeutics | RLAY | Jan 15, 2025 | 3.81 | -12.31 |
Reliance | RS | Jan 15, 2025 | 281.99 | +1.52 |
Reliance Global | RELI | Jan 15, 2025 | 2.10 | -5.41 |
Relmada Therapeutics | RLMD | Jan 15, 2025 | 0.40 | -0.90 |
RELX ADR | RELX | Jan 15, 2025 | 47.06 | +2.13 |
Remitly Global | RELY | Jan 15, 2025 | 23.00 | +2.68 |
Renaissance Ipo ETF | IPO | Jan 15, 2025 | 44.95 | +2.35 |
RenaissanceRe | RNR | Jan 15, 2025 | 255.00 | +1.54 |
RenaissanceRe G Pref | RNR-G | Jan 15, 2025 | 16.57 | +2.86 |
RenaissanceRe Holding F Pref | RNR-F | Jan 15, 2025 | 22.55 | +2.00 |
Renasant | RNST | Jan 15, 2025 | 36.01 | +0.90 |
ReNew Energy Global A Shares | RNW | Jan 15, 2025 | 6.70 | +2.29 |
Renn Fund | RCG | Jan 15, 2025 | 2.56 | +0.39 |
Renovaro Biosciences | RENB | Jan 15, 2025 | 0.78 | -4.42 |
RenovoRx | RNXT | Jan 15, 2025 | 1.41 | +6.82 |
Rent The Runway A | RENT | Jan 15, 2025 | 8.63 | +7.74 |
Rentokil Initial ADR | RTO | Jan 15, 2025 | 23.84 | +2.32 |
Repare Therapeutics | RPTX | Jan 15, 2025 | 1.28 | +0.79 |
Repay A | RPAY | Jan 15, 2025 | 7.43 | -0.27 |
Repligen | RGEN | Jan 15, 2025 | 157.29 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.